Squamous cell carcinomas
Showing 1 - 25 of >10,000
Stage T3 Squamous Cell Carcinomas of the Scalp
Active, not recruiting
- Squamous Cell Carcinoma
- +2 more
-
Maastricht, NetherlandsEllen Oyen
Aug 3, 2023
Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +3 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
May 17, 2023
T1 Squamous Cell Carcinomas of the Lip
Active, not recruiting
- Lip
- +9 more
-
Nijmegen, Gelderland, Netherlands
- +2 more
Nov 2, 2022
Squamous Cell Carcinoma, Head Neck Cancer Trial in Tampa (Intensity-modulated radiotherapy, Magnetic Resonance Guidance)
Recruiting
- Squamous Cell Carcinoma
- Head and Neck Cancer
- Intensity-modulated radiotherapy
- Magnetic Resonance Guidance
-
Tampa, FloridaMoffitt Cancer Center
Nov 13, 2023
Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,
Recruiting
- Esophageal Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 25, 2023
Solid Organ Transplant Recipients, Skin Cancer Trial in Australia (Sirolimus Topical Cream, Placebo)
Not yet recruiting
- Solid Organ Transplant Recipients
- Skin Cancer
- Sirolimus Topical Cream
- Placebo
-
Camperdown, New South Wales, Australia
- +5 more
May 8, 2023
Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)
Not yet recruiting
- Squamous Cell Carcinoma of the Oral Cavity
- Circulating tumor DNA detection
-
Rouen, France
- +1 more
Jun 29, 2023
Needs and Preferences of Patients With Head-neck Cutaneous SCC
Active, not recruiting
- Cutaneous Squamous Cell Carcinoma
- +10 more
- Regular care with additional administration of a semi-structured interview
-
Maastricht, NetherlandsMaastricht University Medical Center+
Sep 13, 2023
Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)
Not yet recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab + Dasatinib + Quercetin
- surgery
- (no location specified)
Feb 2, 2023
Esophageal Squamous Cell Carcinomas, Concurrent Chemoradiotherapy, Immunotherapy Trial (chemo combined with PD-1 inhibitors)
Not yet recruiting
- Esophageal Squamous Cell Carcinomas
- +3 more
- chemotherapy combined with PD-1 inhibitors
- (no location specified)
Nov 17, 2022
Squamous Cell Carcinoma of Head and Neck, Chemo Induced Nausea and Vomiting Trial (nurse-led standardized intervention)
Not yet recruiting
- Squamous Cell Carcinoma of Head and Neck
- Chemotherapy Induced Nausea and Vomiting
- nurse-led standardized intervention
- (no location specified)
Mar 29, 2023
Squamous Cell Carcinomas of the Head and Neck Trial in Taipei county (Fucoidan, Placebo( Potato starch))
Recruiting
- Squamous Cell Carcinomas of the Head and Neck
- Fucoidan
- Placebo( Potato starch)
-
Taipei county, TaiwanNational Taiwan University Hospital
Mar 14, 2022
Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil
Recruiting
- Superficial Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Combination cream of 5-fluorouracil and calcipotriene
- 5-fluorouracil cream
-
Boston, MassachusettsBoston Medical Center Dermatology Clinic
Nov 9, 2022
Squamous Cell Carcinoma of Head and Neck Trial in Aurora (sEphB4-HSA with chemo, Cetuximab, Radiation Therapy)
Completed
- Squamous Cell Carcinoma of Head and Neck
- sEphB4-HSA with chemotherapy
- +2 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 9, 2022
Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Malignant Solid Neoplasm
- Alisertib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Squamous Cell Carcinoma of the Head and Neck Trial in Tampa (Cisplatin, Stereotactic Body Radiation Therapy (SBRT))
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cisplatin
- Stereotactic Body Radiation Therapy (SBRT)
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022
Head-and-neck Squamous Cell Carcinoma Trial in Germany (De-escalation radio(chemo)therapy - Level 1, De-escalation
Recruiting
- Head-and-neck Squamous Cell Carcinoma
- De-escalation radio(chemo)therapy - Level 1
- +2 more
-
Freiburg, Baden-Wuerttemberg, Germany
- +9 more
Aug 2, 2022
Head and Neck Squamous Cell Carcinomas Trial in Guanzhou (drug, procedure, radiation)
Recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab(neoadjuvant)
- +6 more
-
Guanzhou, Guangdong, ChinaSun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Oct 28, 2022
Head and Neck Tumors, Swallowing Sparing IMRT Trial in Jhajjar (Swallowing and submandibular sparing IMRT)
Recruiting
- Head and Neck Neoplasms
- Swallowing Sparing IMRT
- Swallowing and submandibular sparing IMRT
-
Jhajjar, Haryana, IndiaNci, Aiims
Jan 17, 2022
Esophageal Squamous Cell Carcinomas Trial in Beijing (SI-B001, Irinotecan)
Recruiting
- Esophageal Squamous Cell Carcinomas
-
Beijing, Beijing, ChinaBeijing Cancer Hostital
Mar 14, 2022
Head Neck Cancer Trial in Houston (drug, other, behavioral)
Active, not recruiting
- Head and Neck Cancer
- Docetaxel
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 31, 2022
Decisional Conflicts, Health-related QoL and Satisfaction With
Recruiting
- Cutaneous Squamous Cell Carcinoma
- +9 more
- Regular care with additionally administration of questionnaires
-
Nijmegen, Gelderland, Netherlands
- +1 more
Jul 28, 2022
Head and Neck Squamous Cell Carcinomas Trial in Guangzhou (Consolidation Toripalimab)
Recruiting
- Head and Neck Squamous Cell Carcinomas
- Consolidation Toripalimab
-
Guangzhou, Guangdong, China
- +1 more
Oct 2, 2021
HRQoL Keratinocyte Carcinomas
Enrolling by invitation
- Basal Cell Carcinoma
- +2 more
- questionnaires
-
Ghent, Belgium
- +1 more
Jan 25, 2023